Thermo Fisher Scientific Inc (TMO)
Official siteHEALTHCARE • DIAGNOSTICS & RESEARCH • NYSE
Market Cap: $259.44B
Last updated: Nov 17, 2026 at 11:06 AM ET
Thermo Fisher Scientific Inc (TMO) P/E Ratio & Valuation History
Thermo Fisher Scientific (TMO) trades at 28.0x trailing earnings and 5.4x sales. Its P/E of 28.0x is above its 5-year median of 24.1x. Its forward P/E is 25.1x. The median P/E across 11 similar companies is 28.5x.
Current Multiples
Its forward P/E is below its trailing P/E, which implies earnings per share about 11.6% higher over the next year. Its free cash flow yield is 3.0%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 28.0x |
| Forward P/E | 25.1x |
| Price to sales | 5.4x |
| Price to book | 4.7x |
| EV/EBITDA | 25.2x |
| Price to FCF | 33.7x |
| EV/FCF | 38.4x |
| PEG | 2.0 |
| FCF yield | 3.0% |
Historical Medians
Against its 10-year medians, its P/E is 19.7% above 23.4x, its P/S is 12.5% above 4.8x and its P/B is 9.3% above 4.3x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | 28.0x | 24.1x | 23.4x |
| P/S | 5.4x | 4.9x | 4.8x |
| P/B | 4.7x | 4.6x | 4.3x |
Valuation History
Over the 10 year ends shown, its P/E ranged from 17.1x in 2016 to 26.6x in 2021.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $579.45 | 25.3x | 4.9x | 4.1x |
| 2024 | $520.23 | 23.8x | 4.6x | 4.0x |
| 2023 | $530.79 | 24.6x | 4.8x | 4.4x |
| 2022 | $550.69 | 23.7x | 4.8x | 4.9x |
| 2021 | $667.24 | 26.6x | 6.7x | 6.5x |
| 2020 | $465.78 | 23.8x | 5.7x | 5.4x |
| 2019 | $324.87 | 26.3x | 5.1x | 4.4x |
| 2018 | $223.79 | 20.1x | 3.7x | 3.3x |
| 2017 | $189.88 | 20.0x | 3.6x | 3.0x |
| 2016 | $141.10 | 17.1x | 3.1x | 2.6x |
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About TMO
What is TMO's forward P/E ratio?
Thermo Fisher Scientific has a forward P/E ratio of 25.1x.
Is TMO stock overvalued?
GNG's valuation label for TMO is Fairly valued. Its P/E of 28.0x compares with a median of 28.5x across 11 similar companies.
What is TMO's price to sales ratio?
Thermo Fisher Scientific has a price to sales ratio of 5.4x.
What is Thermo Fisher Scientific's average P/E ratio over 5 years?
Thermo Fisher Scientific's median P/E over the last 5 years is 24.1x, from 60 month-end values through Oct 2026.
What is TMO's PEG ratio?
Thermo Fisher Scientific has a PEG ratio of 2.0.
TMO pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts